Rosario Notaro
Overview
Explore the profile of Rosario Notaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1585
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Kulasekararaj A, Risitano A, Maciejewski J, Notaro R, Browett P, Lee J, et al.
Blood
. 2021 Jul;
138(20):1928-1938.
PMID: 34314483
Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by uncontrolled terminal complement activation and subsequent intravascular hemolysis (IVH). C5 inhibitors prevent membrane attack complex formation, but patients may experience extravascular hemolysis (EVH)...
13.
Debureaux P, Kulasekararaj A, Cacace F, Silva B, Calado R, Barone F, et al.
Bone Marrow Transplant
. 2021 Jul;
56(10):2600-2602.
PMID: 34226670
No abstract available.
14.
Luzzatto L, Risitano A, Notaro R
N Engl J Med
. 2021 Jun;
384(22):2164.
PMID: 34077653
No abstract available.
15.
Barcellini W, Fattizzo B, Giannotta J, Quattrocchi L, Aydin S, Barone F, et al.
Br J Haematol
. 2021 May;
194(5):854-856.
PMID: 34036575
No abstract available.
16.
Risitano A, Kulasekararaj A, Lee J, Maciejewski J, Notaro R, Brodsky R, et al.
Haematologica
. 2020 Oct;
106(12):3188-3197.
PMID: 33121236
Paroxysmal nocturnal hemoglobinuria (PNH) is characterised by complement-mediated intravascular hemolysis (IVH) due to absence of complement regulators CD55 and CD59 on affected erythrocytes. Danicopan is a first-in-class oral proximal, complement...
17.
Sica M, Pellecchia A, De Angioletti M, Caocci G, Nannelli C, La Nasa G, et al.
Blood
. 2020 Aug;
136(26):3082-3085.
PMID: 32845970
No abstract available.
18.
Cosi I, Pellecchia A, De Lorenzo E, Torre E, Sica M, Nesi G, et al.
J Hematol Oncol
. 2020 Aug;
13(1):112.
PMID: 32791988
Background: ETV4 is one of the ETS proteins overexpressed in prostate cancer (PC) as a result of recurrent chromosomal translocations. In human prostate cell lines, ETV4 promotes migration, invasion, and...
19.
Luzzatto L, Ally M, Notaro R
Blood
. 2020 Jul;
136(11):1225-1240.
PMID: 32702756
Glucose 6-phosphate dehydrogenase (G6PD) deficiency is 1 of the commonest human enzymopathies, caused by inherited mutations of the X-linked gene G6PD. G6PD deficiency makes red cells highly vulnerable to oxidative...
20.
Risitano A, Marotta S, Ricci P, Marano L, Frieri C, Cacace F, et al.
Front Immunol
. 2019 Jul;
10:1157.
PMID: 31258525
The treatment of paroxysmal nocturnal hemoglobinuria has been revolutionized by the introduction of the anti-C5 agent eculizumab; however, eculizumab is not the cure for Paroxysmal nocturnal hemoglobinuria (PNH), and room...